Stockreport

Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results

AnaptysBio, Inc.  (ANAB) 
Last anaptysbio, inc. earnings: 3/2 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com/investor-relations
PDF Spin-off of biopharma operations into a public company to be called “First Tracks Biotherapeutics” on track for Q2 2026, potentially as early as late-AprilPhase 1b enrol [Read more]